A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.read more >>
Prime Global Buzz.
News and views from our business and beyond
Pick a category
Welcoming our newest IGNITE cohort!Prime Global 13 June, 2022
The Corporate Reputation of Pharma in 2021Prime Global 31 May, 2022
This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
Not just a buzzword: how Pharma and advocacy leaders are effecting meaningful patient centricityPrime Global 30 May, 2022
On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Evolving applications of omics in healthcarePrime Global 25 May, 2022
Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.
Haemophilia awareness: building trusted relationships between patients and industryPrime Global 19 April, 2022
Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
Prime Patient collaborate with award-winning advocate Trishna Bharadia to explore how industry can better engage with people living with multiple sclerosis (PwMS) this MS Awareness Month.
We caught up with Senior Account Executive Pamela Lopez, to find out more about her role and our Ignite scheme!read more >>
Patient engagement in rare mutation cancersPrime Global 4 March, 2022
Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.
In the spirit of Rare Disease Day, which was celebrated on 28 February, we’re looking at the importance of patient engagement in lysosomal storage disorders (LSDs).